A previous study observed that the administration of anti-TNF-α antibodies to neonatal rats model with NEC significantly lowered hepatic and intestinal levels of TNF-α and IL-18.93 This intervention also reduced intestinal wall permeability and the expression of pro-apoptotic markers such as Bax and cleaved caspase-3. This evidence concerns the gene TNF and necrotizing enterocolitis.